SS Innovations International, Inc SSII

The program began with a robotic left internal mammary artery ("LIMA") take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra advanced robotic surgical system from SS Innovations. SS Innovations reported 23...

The company reported continued growth of its SSi Mantra surgical robotic system, with installations reaching 238 as of September 8, 2026, with the installed base now spanning 12 countries, following recent launches in Colombia and Sri Lanka and furt...

The company has supported the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted LIMA takedown, performed by SS Innovation...

LOS ANGELES, CA - September 10, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Se...

-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company’s continuing progre

SS Innovations is scaling its SSi Mantra surgical robotic system from an established Indian base into international markets. Second-quarter revenue rose 39.4% year over year to $13.9 million, while 30 SSi Mantra systems were installed during the qua...

SS Innovation's SSi Mantra system was used in more than 50 robotic surgeries in a single day at Mohak Bariatrics and Robotics in Indore, highlighting growing clinical utilization in India. The milestone comes as SS Innovations reports 224 SSi Mantra...

SS Innovations, developer of innovative surgical robotic technologies, reported record second-quarter revenue of $13.9 million, up 39.4% year over year. First-half revenue reached $25.0 million, a 65.6% increase from the same period in 2025. The com...

LOS ANGELES, CA - August 14, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic...

Record quarterly revenue driven by continuing strong growth in SSi Mantra unit salesFORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2026. The Company also filed its

The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform. The company's strategy combines world-class robotic systems, including telesurgery capabilities, with affordabi...

SS Innovations will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery ("SRS") 2026 Annual Meeting in Florida on July 23-26. The presentation will feature a live kidney telesurgery broadcast from India, demonstrating t...

The company has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, h...

Company’s advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry eventFORT LAUDERDALE, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today annou

LOS ANGELES, CA - July 15, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, ...

SS Innovations International, Inc. (NASDAQ:SSII) is one of the best strong buy penny stocks to invest in now. SS Innovations International, Inc. (NASDAQ:SSII) announced on July 7 that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), graduated its first class in a specialised training course specialised to offer classroom instruction and hands-learnings in […]

Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.

LOS ANGELES, CA - July 14, 2026 (NEWMEDIAWIRE) - For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview w...

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growthFORT LAUDERDALE, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Sarah M. Romano as